Lee Buckler is a true stem cell industry guru. As I’ve been writing this blog for the last couple years it has served as a catalyst for me to meet dozens of really interesting people including. Given all the complex events of late in the stem cell field, I asked Lee if he would do an […]
Great interview with Lee Buckler on stem cell industry, regulatory issues, and Celltex Read More »
What does the future hold for the privately-held Texas stem cell clinic, Celltex, that had given Governor Perry a stem cell transplant? I put up a poll a few days ago asking this question and the results have been striking. By way of background, it’s been a complicated few weeks for Celltex. Almost a month ago, I
Poll indicates major pessimism on future of Texas stem cell clinic, Celltex Read More »
Medulloblastoma is the most common pediatric brain tumor. However, treatments for children who are diagnosed with so-called medullos have not evolved much over the years and are largely similar to treatments given to adults for other brain tumors. One frequent event in certain medullos is amplification of two members of the MYC family of oncogenes
New medulloblastoma paper suggests novel avenues to treat this childhood cancer Read More »
As I first reported, the FDA conducted a two-week audit of Texas adult stem cell firm, Celltex, sometime in April. Today I received a copy of the so-called “483 report” of that audit. It is basically a summary of problematic issues that the FDA says need to addressed. The FDA report is cause for some
Surprising FDA audit report of Celltex a blow to dubious stem cell clinics Read More »
Open access publishing is getting a lot of attention. Taxpayer supported government grants + scientists’ work = closed access publisher profits (derived from payments from taxpayers + scientists) This simple equation embodies all that is wrong with today’s predominant system of publishing. In fact, it is an indictment of closed access publishers. The profits of
The case for open access publishing embodied in a single equation Read More »
The FDA has been busy with stem cell-related activities this spring including with ICMS. Busier than publicly apparent. Very busy, indeed! Earlier, I reported that they issued a warning letter to cosmetician to the stars, Dr. LookGood, as well as one to another doc selling stem cell therapies. Now it seems apparent that even more
FDA visits both ICMS and reportedly Celltex Read More »
On Monday, I made a big stink about Texas GOP Governor Rick Perry visiting a lab (that of Jeanne Loring) at Scripps Research Institute here in California because the lab in question is a leading group doing human embryonic stem cell (HESC) and Perry is a strong opponent of such research. I thought the visit
Great letter on Guv Perry’s California visit video from the artist Read More »
In terms of contact information, this site is produced by the Knoepfler Lab at UC Davis School of Medicine in Sacramento, CA, but our official address is 1 Shields Ave, Davis, CA 95616. The posts are generally written by Dr. Paul Knoepfler who can be reached at knoepfler@ucdavis.edu. You can also reach out to contact
Yesterday I posted an interesting interview with ICMS President Dr. Ricardo Rodriguez. I again thank Rodriguez for participating. Please note that one issue that I had already raised to Dr. Rodriguez was that I could not find the membership of their IRB listed on their website and this was apparently just addressed as that information can
Recommendations to ICMS for improved practices Read More »
The International Cellular Medicine Society (ICMS) has emerged as an important organization related to stem cell regulatory issues. I think that many people do not understand what ICMS is all about and it certainly evokes strong opinions in the stem cell field. If you care about stem cells then you need to know about ICMS
ICMS President Rodriguez interview on adult stem cell regulatory issues Read More »